SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

5 marketing jobs

7 days ago

Senior Campaign Manager

Illumina

Boulder, CO (Unknown)Full time$108K/yr – $162K/yr
7 days ago

Senior Campaign Manager

Illumina

San Diego, CA (On-site)Full time$108K/yr – $162K/yr
3 weeks ago

Senior Events Specialist, USCAN Field Marketing

Illumina

San Diego, CA (On-site)Full time$83K/yr – $124K/yr
5 weeks ago

Associate Director of Public Relations

Illumina

San Diego, CA (Hybrid)Full time$156K/yr – $233K/yr
1 month ago

Staff Marketing Programs Manager

Illumina

San Diego, CA (On-site)Full time$118K/yr – $177K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

5 jobs

Senior Campaign Manager

Illumina

Boulder, CO (Unknown)

$108K/yr - $162K/yrIn-houseFull-timeSenior level
7 days ago

Senior Campaign Manager

Illumina

San Diego, CA (On-site)

$108K/yr - $162K/yrIn-houseFull-timeSenior level5+ years exp.
7 days ago

Senior Events Specialist, USCAN Field Marketing

Illumina

San Diego, CA (On-site)

$83K/yr - $124K/yrIn-houseFull-timeSenior level5+ years exp.
3 weeks ago

Associate Director of Public Relations

Illumina

San Diego, CA (Hybrid)

$156K/yr - $233K/yrIn-houseFull-timeSenior level15+ years exp.
5 weeks ago

Staff Marketing Programs Manager

Illumina

San Diego, CA (On-site)

$118K/yr - $177K/yrIn-houseFull-timeSenior level8+ years exp.
1 month ago
Illumina

Senior Campaign Manager

Boulder, CO (Unknown)

$108K/yr – $162K/yrSenior LevelFull time

Posted 7 days ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Own and drive multi-channel marketing campaigns from planning through optimization, coordinating Product Marketing, Creative, Sales and Digital teams to ensure consistency and impact.

  • Lead integrated programs across digital and traditional channels
  • Oversee paid media and optimization across Google Ads, Meta, and LinkedIn

Job Description

Responsibilities

  • Develop and execute integrated marketing campaigns across digital and traditional channels, ensuring alignment with brand goals and revenue objectives.
  • Manage the full campaign lifecycle from planning and audience segmentation to launch, performance tracking, and optimization.
  • Collaborate with cross-functional teams including Product Marketing, Creative, Sales, and Digital to maintain campaign consistency and effectiveness.
  • Oversee paid media strategy across platforms such as Google Ads, Meta, and LinkedIn, optimizing targeting and creative based on performance insights.
  • Utilize HubSpot and Pardot to build workflows, lead nurturing sequences, and personalized customer experiences.
  • Conduct A/B testing, optimize landing pages, and analyze performance using Google Analytics and other tools to boost conversion rates and ROI.
  • Monitor key performance indicators, build campaign dashboards, and present insights to stakeholders to guide data-driven decisions.

Requirements

  • Typically requires a minimum of 5 years of related experience with a Bachelor’s degree; or 3 years and a Master’s degree; or a PhD without experience; or equivalent work experience.
  • Experience managing integrated, multi-channel marketing campaigns from planning through optimization, ideally in a B2B or life sciences environment.
  • Hands-on proficiency with marketing automation platforms (HubSpot and/or Pardot), including workflow and lead nurture build.
  • Working knowledge of paid media platforms (Google Ads, Meta, LinkedIn) and campaign-level budget management.
  • Comfort with A/B testing, landing page optimization, and web analytics tools (Google Analytics) to drive conversion improvements.
  • Strong cross-functional collaboration skills, with the ability to align Sales, Product Marketing, and Creative around a single campaign plan.
  • Ability to build and present clear performance dashboards and translate campaign data into recommendations for stakeholders.

Benefits

  • We offer a wide range of benefits as innovative as our work, including access to genomics sequencing, family planning, health/dental/vision, retirement benefits, and paid time off.

Illumina

3.5 Glassdoor

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Founded in 1998
San Diego, California, USA
9.3K employees (329 in marketing)
www.illumina.com
62% recommend to a friend
75% CEO approval

Salaries

Posted range

$108K/yr – $162K/yr

Taken straight from the job posting.

See all Illumina salaries

Marketing Team

Marketing Team Size
247 (3% of company)
Median Career Experience
16 years
Median Tenure
5.2 years
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$1.3B
Last Raise
$500M
Post IPO Debt, 2 years ago

Funding History

  • Sep 2024
    Post IPO Debt • $500M
  • Jan 2023
    Post IPO Debt • $750M
  • Jan 2000
    Series Unknown • $28M

Traffic Signals

Monthly Visitors
828K
Monthly Google Ads Budget
$27.5K
Traffic Source Mix
Search
46.3%
Direct
42.2%
Referral
9.4%
Social
1.2%
Paid
0.8%

Headcount Trend

Current headcount: ~9.3K

Recent News

Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Nov 5, 2025 • PR Newswire
Why Illumina (ILMN) Stock Is Up Today
Oct 31, 2025 • Yahoo Finance
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies
Oct 31, 2025 • Fierce Biotech
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
Oct 30, 2025 • PR Newswire
10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents
Oct 23, 2025 • IPWatchdog.com
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents
Oct 23, 2025 • Genetic Engineering and Biotechnology News
10x sues rival Illumina over gene-sequencing patents
Oct 21, 2025 • Reuters
Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina.
Oct 16, 2025 • Barron's
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Oct 15, 2025 • PR Newswire
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Oct 15, 2025 • Illumina
Illumina launches new business to accelerate technology and data-driven discovery
Oct 1, 2025 • Illumina
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities | Scientific Reports
Sep 29, 2025 • Nature
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting
Sep 26, 2025 • Nature
Alnylam Joins Illumina and NashBio for Faster, More Inclusive Drug Discovery
Sep 25, 2025 • Inside Precision Medicine
Illumina advances personalized cancer care with new pharma development partnerships
Sep 23, 2025 • MarketScreener
Illumina advances personalized cancer care with new pharma development partnerships
Sep 23, 2025 • Morningstar.com
Illumina to partner with multiple global pharmaceutical companies
Sep 23, 2025 • thefly.com
Illumina advances personalized cancer care with new pharma development partnerships
Sep 23, 2025 • sdbn.org
Element Biosciences Sues Illumina Alleging Anticompetitive Behavior, Patent Infringement
Sep 22, 2025 • GenomeWeb
Illumina sued by rival Element over gene-sequencing technology
Sep 22, 2025 • Reuters
In Brief This Week: Illumina, Bionano Laboratories, MDxHealth, ARUP Laboratories, More
Sep 19, 2025 • GenomeWeb
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
Sep 18, 2025 • PR Newswire
US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux
Sep 18, 2025 • Research and Markets
Liquid Biopsy Market Size Worth USD 22.69 Billion by 2034 Amid Rising Demand for Minimally Invasive Cancer Testing
Sep 16, 2025 • Precedence Research
This startup CEO says he can 'help you lead a healthy life to 100'
Sep 15, 2025 • Joins.com
One Year After Illumina/Grail – How Are EU Competition Authorities Now Dealing With Below-Threshold Mergers
Sep 11, 2025 • Crowell & Moring LLP
China’s Domestic Sequencers Take Bigger Market Share in First Half After Illumina Import Ban
Sep 11, 2025 • yicaiglobal.com
Comprehensive Report on the Hyper-Personalized Medicine Market: Opportunities and Challenges
Sep 11, 2025 • EIN Presswire
‘Pushing physics to the limit’: MGI’s DNA sequencers gaining in the market, BGI CEO says
Sep 11, 2025 • South China Morning Post
Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
Sep 10, 2025 • Research and Markets
MGI Tech's T7+ Sequencer Promises to Churn out 35K Human Genomes per Year
Sep 9, 2025 • GenomeWeb
China’s MGI Tech touts world’s fastest gene sequencer: 10 minutes to read a genome
Sep 9, 2025 • South China Morning Post
Angle PLC Announces Interim Results
Sep 8, 2025 • Morningstar.com
Carrier Screening Market to Reach USD 5.8 Bn by 2035, Growing at 11.8% CAGR | Transparency Market Research
Sep 8, 2025 • EIN Presswire
Illumina Protein Prep solution the new standard in proteomics
Sep 3, 2025 • Illumina
The Crunchbase Tech Layoffs Tracker
Sep 3, 2025 • Crunchbase News
Global Bioinformatics Market to Grow at 13-14% CAGR, Driven by Genomics & Drug Discovery by 2029
Sep 2, 2025 • PharmiWeb
Noninvasive Cancer Diagnostics Market to Hit USD 255.25 Billion by 2033 | 9.9% CAGR Driven by Liquid Biopsy
Sep 2, 2025 • EIN Presswire
MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions
Sep 2, 2025 • Newswire
Scan, Play, Discover: Orca Scan Launches QR-Powered Retro Game
Sep 2, 2025 • prnasia.com
NGS-Based AMR Detection Market Set to Double by 2035, Unlocking Growth Opportunities for Manufacturers
Aug 28, 2025 • EIN Presswire
Life Science Tools Market to Grow at a CAGR of 10.81% from 2025 to 2032 | SkyQuest Technology Consulting
Aug 28, 2025 • PR Newswire
Genetic Material Market Size, Trends and Top Companies (2025 – 2034 Forecast Period)
Aug 28, 2025 • Precedence Research
The Necessity of Investing Shown in One Chart Contributed Opinion
Aug 26, 2025 • streetwisereports.com
STAT+: Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty
Aug 26, 2025 • STAT
Single Cell Sequencing Market worth $3.46 billion by 2030 with 12.2% CAGR | MarketsandMarkets™
Aug 25, 2025 • PR Newswire
Genomics in Cancer Care Market Set to Revolutionize Oncology: Key Trends, Growth Drivers, and Future Opportunities 2025
Aug 25, 2025 • EIN Presswire
Single Cell Sequencing Market worth $3.46 billion by 2030 with 12.2% CAGR | MarketsandMarkets™
Aug 25, 2025 • PR Newswire UK
Global Liquid Biopsy Market Set to Reach USD 7.05 Billion by 2030 | MarketsandMarkets™
Aug 22, 2025 • MarketsandMarkets Research Pvt. Ltd.
Epigenetics Market Size, Growth Trends, Opportunities & Forecast 2025–2035
Aug 21, 2025 • PharmiWeb
global next generation sequencing market
Aug 20, 2025 • PharmiWeb
Nilesh Shah joins Illumina as Head of Region, AMEA
Aug 19, 2025 • prnasia.com
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
Aug 18, 2025 • Biocartis NV
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited
Aug 15, 2025 • Benzinga.com
Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™
Aug 15, 2025 • PR Newswire UK
Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™
Aug 15, 2025 • PR Newswire
Carl Icahn raises shared share stake in Centuri Holdings, dissolves in Dana, Illumina
Aug 14, 2025 • MarketScreener
Trump's trade war with China in 2025
Aug 12, 2025 • MarketScreener
Precision Medicine Market Projected to Leap from USD 98.3 Billion in 2024 to USD 365.5 Billion by 2033 at a 15.8% CAGR
Aug 12, 2025 • PharmiWeb
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
Aug 12, 2025 • Research and Markets
Unlocking Precision: The Rise of Oncology Companion Diagnostics in Personalized Cancer Care | DataM Intelligence
Aug 11, 2025 • EIN Presswire
Standard BioTools Reports Second Quarter 2025 Financial Results
Aug 11, 2025 • Standard BioTools Inc.
Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024
Aug 11, 2025 • Research and Markets
Prenatal Genetic Testing Market Size, Trends & Future For...
Aug 11, 2025 • PharmiWeb
global ovarian cancer diagnostics market
Aug 8, 2025 • PharmiWeb
Precision Medicine Market to Surge to USD 365.5 Bn by 2033 – Ameco Research Forecasts 15.8% CAGR
Aug 8, 2025 • PRLog
Non-Invasive Prenatal Testing Market Trends and Forecast Report 2025-2033 | Technological Advances, Rising Awareness, and Personalized Medicine Bolster Growth - ResearchAndMarkets.com
Aug 7, 2025 • Business Wire
Liquid Biopsy Market worth US$7.05 billion by 2030 with 11.8% CAGR | MarketsandMarkets™
Aug 5, 2025 • PR Newswire
Liquid Biopsy Market worth US$7.05 billion by 2030 with 11.8% CAGR | MarketsandMarkets™
Aug 5, 2025 • PR Newswire UK
Illumina price target raised by $5 at Stephens, here's why
Aug 4, 2025 • thefly.com
Ovarian Cancer Diagnostics Market to Hit USD 7.28 Billion by 2032 | Growing at 5.06% CAGR - SNS Insider
Aug 4, 2025 • SNS Insider pvt ltd
STAT+: Uncertainty clouds the San Diego biotech hub, with jobs and capital scarce
Aug 4, 2025 • sdbn.org
STAT+: Uncertainty clouds the San Diego biotech hub, with jobs and capital scarce
Aug 4, 2025 • STAT
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles
Aug 4, 2025 • ION Analytics
Global Cell Analysis Market: Growth, Drivers, and Segment Insights (2023-2032)
Aug 4, 2025 • EIN Presswire
Platinum Pedigree Benchmark Boosts AI Accuracy in Genomic Variant Detection
Aug 4, 2025 • Genetic Engineering News
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion
Aug 2, 2025 • Benzinga.com
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
Jul 30, 2025 • Illumina
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
Jul 30, 2025 • MarketScreener
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
Jul 30, 2025 • PR Newswire
Molecular Diagnostics Market to Hit USD 33.7 Billion by 2032, Growing at 7.3% CAGR | SkyQuest Technology Consulting
Jul 29, 2025 • PR Newswire UK
Genomics Market Surges with PCR and AI Technologies Projected to Reach USD 175.18 Billion by 2034
Jul 29, 2025 • BioSpace
Molecular Diagnostics Market to Hit USD 33.7 Billion by 2032, Growing at 7.3% CAGR | SkyQuest Technology Consulting
Jul 29, 2025 • PR Newswire
Next-Gen Sequencing Market to Reach $35.9B by 2033, Driven by Diagnostics, Innovation & Global Demand
Jul 28, 2025 • EIN Presswire
Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
Jul 28, 2025 • Research and Markets
A Vision for Illumina: A Conversation with Jacob Thaysen
Jul 25, 2025 • sdbn.org
RFK Jr. Taps Drug Chief From Revolving Door He Vowed to Close
Jul 25, 2025 • bloomberglaw.com
Nanopores Inside and Out, a Fireside Chat with Clive Brown
Jul 25, 2025 • sdbn.org
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth
Jul 25, 2025 • Research and Markets
Companion Diagnostics Market Forecast Report 2025-2034 | Next-Generation Sequencing Enhancing Accuracy, Precision Medicine Advancements Propel Growth
Jul 23, 2025 • Research and Markets
Nucleic Acid Extraction System Market to Expand at a CAGR of 11.4% by 2035 | Fact.MR
Jul 23, 2025 • EIN Presswire
Clinical Next Generation Sequencing Market Trends and Forecasts Report 2025-2032 | Personalized Medicine and R&D Investments Propel Growth
Jul 23, 2025 • Research and Markets
Cancer Diagnostics Market Outlook 2025–2035: Innovations,...
Jul 22, 2025 • PharmiWeb
Global Cancer Biomarkers Market Size to Reach USD 72.64 Billion by 2032, Driven by Precision Oncology and Early Detection Advancements - SNS Insider
Jul 21, 2025 • SNS Insider pvt ltd
Cote d'Ivoire IVD Market Forecast Report 2025-2032 | Opportunities in Public-Private Partnerships, Molecular Diagnostics Demand, Telemedicine and Point-of-Care Testing
Jul 21, 2025 • Research and Markets
Kidney Cancer Diagnostics Market to Reach USD 2,015.3 Mn by 2035, Fuelled by Rising Cancer Prevalence
Jul 21, 2025 • EIN Presswire
U.S. In Vitro Diagnostics (IVD) Market and Competition Insights 2025-2034 - Next-Gen Genomic Tools and Decentralized Testing to Transform U.S. Diagnostics Landscape
Jul 21, 2025 • Research and Markets
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche
Jul 18, 2025 • Research and Markets
Illumina Stock: What Went Wrong And Why It's Best To Stay Away
Jul 17, 2025 • Benzinga.com
Comprehensive genomic profiling linked to higher targeted therapy use, with Medicare patients lagging behind
Jul 16, 2025 • Medical Xpress - latest medical and health news stories

Links

www.illumina.comLinkedInX (Twitter)Crunchbase